medigraphic.com
ISSN 2448-8011 (Electronic)
Revista de Divulgación del INSTITUTO DE MEDICINA FORENSE de la UNIVERSIDAD VERACRUZANA

2017, Number 2

<< Back

Rev Mex Med Forense 2017; 2 (2)

Relationship between suicidal behavior, serum lipid levels and neurobiological implications: a review

Denis RE, Barradas AME, Delgadillo CR, Siliceo BJ

Language: Spanish
References: 36
Page: 62-71
PDF size: 229.12 Kb.


ABSTRACT

Suicide is a global health problem that causes a high morbidity and mortality rate in young individuals. Although it has been postulated that it is a phenomenon of social and cultural origin, in the last 40 years it has been linked with genetic, neurophysiological and biochemical factors. These include lipid concentrations in serum and brain tissue In this review we analyze the evidence linking the lipid profile with suicidal behavior in both normal individuals and those with psychiatric disorders such as depression, bipolar disorder and schizophrenia; finally we analyze theories which have been designed to explain why the concentration of lipid may be associated with suicidal ideation, suicide attempts and completed suicide.


REFERENCES

  1. Ahmadpanah M, Haghighi M, Jahangard L (2015). No evidence for metabolic syndrome and lipid profile differences in patients suffering from bipolar I disorder with and without suicide attempts. Int J Psychiatry Clin Pract. 19(3):168-73.

  2. Ainiyet B, Rybakowski JK (2014). Suicidal behavior in schizofrenia may be related to low lipid levels. Med Sci Monit. 20:1486-90.

  3. Atmaca M, Kuloglu M, Tezcan E (2003). Serum leptin and colesterol levels in schizophrenic patients with and without suicide attempts. Acta Psychiatr Scand. 108:208–14.

  4. Antypa N, Serreti A, Rujescu D (2015). Serotonergic genes and suicide: a systematic review. Eur Neuropsychopharmacol. 23(10):1125-42.

  5. Arango V, Huang YY, Underwood MD (2003). Genetics of the serotonergic system in suicidal behavior. Psychiatr Res.37(5):375-86.

  6. Asellus P, Nordstrom P, Nordstrom AL (2014). Cholesterol and the “cycle of violence” in attempted suicide. Psychiatry Res. 215(3):646-50.

  7. Asellus P, Norstrom P, Nordstrom AL (2016). Plasma apolipoprotein E and severity of suicidal behaviour, J Affect Disord. 190:137-42.

  8. Baek JH, Kang ES, Fava M (2014). Serum lipids, recent suicide attempt and recent suicide status in patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 51:113-8.

  9. Berlin I, Luquiens A, Aubin HJ (2016). Smoking as a confounder of the association of suicidality with serum lipid levels. J Psychiatry Neurosci, 41(2): E24.

  10. Boulougouris V, Malogiannis I, Lockwood G (2013). Serotonergic modulation of suicidal behaviour: integrating preclinical data with clinical practice and psychotherapy. Exp Brain Res. 230(4):605-24.

  11. Cantarelli M, Nardin P, Buffon A (2015). Serum triglycerides, but not cholesterol or leptin, are decreased in suicide attempters with mood disorders. J Affect Disord. 2015, 172:403-9.

  12. Cantarelli F, Tramontina AC, Leite MC (2014). Potential neurochemical links between cholesterol and suicidal behavior. Psychiatry Res. 220(3):745-51.

  13. Emet M, Yucel A, Ozcan H (2015). Female attempted suicide patients with low HDL levels are at higher risk of suicide re-attempt within the subsequent year: a clinical cohort study. Psychiatry Res. 225(1-2):202-7.

  14. Freemantle E, Chen GG, Cruceanu C (2013). Analysis of oxysterols and cholesterol in prefrontal cortex of suicides. Int J Neuropsychopharmacol. 16(6):1241-9.

  15. Grucza RA, Plunk AD, Krauss MJ (2014). Probing the smoking-suicide association: Do smoking policy interventions affect suicide risk? Nicotine Tob Res;16:1487-94.

  16. Hawton K, van Heeringen K (2009). Suicide. Lancet, 373:1372-81.

  17. Kavoor AR, Mitra S, Kumar R. (2017). Lipids, agression, suicidality and impulsivity in drug-naive/druf-free patients of schizofrenia. Asian J Psychiatr, 27: 129-136.

  18. Klinitzke G, Steinig J, Bluher M (2013). Obesity and suicide risk in adults — a systematic review. J Affect Disord;145:277-84.

  19. Lee HJ, Kim YK (2003). Serum lipid levels and suicide attempts. Acta Psychiatr Scand;108:215-21

  20. Mann JJ (2013). The serotonergic system in mood disorders and suicidal behaviour. Philos Trans R Soc Lond B Biol Sci. 368(1615):20120537.

  21. Mensi R, Messaoud A, Mhallah A (2016). The association between altered lipid profile and suicide attempt among Tunisian patients with schizofrenia. Ann Gen Psychiatry, 16: 15-26

  22. O’Connor E, Gaynes BN, Burda BU (2013). Screening for and treatment of suicide risk relevant to primary care: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med, 158:741-54.

  23. Organización Mundial de la Salud (OMS) (2017). Suicidio: nota descriptiva. Recuperado de www.who.int/mediacentre/factsheets/fs398/es/. Consultado el 15 de Julio del 2017.

  24. Organización Panamericana de la Salud (OPS) (2014). Mortalidad por suicidio en las américas. Informe Regional. Washington: OPS.

  25. Oquendo MA, Galfalvy H, Sullivan GM (2016). Positron Emission Tomographic Imaging of the Serotonergic System and Prediction of Risk and Lethality of Future Suicidal Behavior. JAMA Psychiatry. 73(10):1048-1055.

  26. Papadopoulou A, Markianos M, Christodoulou C (2013). Plasma total colesterol in psychiatric patients after a suicide attempt and in follow-up. J Affect Disord. 148(2-3):440-3.

  27. Park S, Yi K, Na R (2013). No association between serum colesterol and death by suicide in patients with schizophrenia, bipolar affective disorder or major depressive disorder. Behav Brain Funct. 9:45.

  28. Park YM, Lee BH, Lee SH (2014). The association between serum lipid levels, suicide ideation, and central serotonergic activity in patients with major depressive disorder. J Affect Disord.159:62-5.

  29. Pérez, BS (1999). El suicidio, comportamiento y prevención. Revista Cubana Medicina General Integral, 15(2): 196-217.

  30. Roaldset JO, Bakken AM, BjørklyS (2011). A prospective study of lipids and serotonin as risk markers of violence and self-harm in acute psychiatric patients. Psychiatry Research,186(2–3), 293–299.

  31. Roaldset JO, Linaker OM (2014). Triglycerides as a biological marker of repeated re-hospitalization resulting from deliberate self-harm in acute psychiatry patients: a prospective observational study. BMC Psychiatry. 14:54.

  32. Shakeri J, Farnia V, Kalinia K (2015). The relationship between lifetime suicide attempts, serum lipid levels, and metabolic syndrome in patients with bipolar disorders. Int J Psychiatry Clin Pract. 19(2):124-31

  33. Shin HY, Kang G, Kang HJ (2016). Associations between serum lipid levels and suicidal ideation among Korean older people. J Affect Disord. 189:192-8.

  34. Sudol J, Mann JJ (2017). Biomarkers of suicide attempt behavior: towards a biological model of risk. Curr Psychiatry Rep, 19(6): 31.

  35. Wu S, Ding Y, Wu F (2016). Serum lipid levels and suicidality: a meta-analysis of 65 epidemiological studies. J Psychiatry Neurosci. 41(1):56-69. Meta-análisis de

  36. Wu S, Hou J, Mao P (2016). Response to “Smoking as a confounder of the association of suicidality with serum lipids. J Psychiatry Neurosci, 41(2): E25.




2020     |     www.medigraphic.com